FibroScan Discordance With Liver Biopsy Significantly Overestimates Advanced Fibrosis and Cirrhosis in MASLD Subjects With Class 3 Obesity
FibroScan significantly overestimates advanced fibrosis and cirrhosis in class 3 obesity. A second noninvasive test is warranted for accurate liver-directed therapeutic allocation and to minimize unnecessary biopsies in MASLD management.
Authors
- Jena Velji-Ibrahim (ORCID: https://orcid.org/0000-0002-5282-0727)
- Jordan Woodard
- Gary A. Abrams (ORCID: https://orcid.org/0000-0001-8036-3861)
- Jay Alden (ORCID: https://orcid.org/0000-0003-4406-3903)
Institutions
- Prisma Health (US)
- University of South Carolina (US)
Publication Details
- Journal
- Journal of Clinical Gastroenterology
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1097/mcg.0000000000002132
- Citations
- 3
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.06